Jane Onken, MD, MHS

Department:
Medicine

Division:
Gastroenterology

Physical Address:
DUMC 3902, Durham, NC 27710

Appointment Telephone:
(919) 684-1817

Fax Telephone:
(919) 681-8147

Training:
M.D., George Washington University School of Medicine, Washington, D.C., 1987
Internal Medicine, Duke University Medical Center, North Carolina, 1987-90
Gastroenterology, Duke University Medical Center, North Carolina, 1990-93
M.H.S., Duke University, North Carolina, 2005

Clinical Interests:
Inflammatory bowel disease, diagnostic and therapeutic endoscopy, GI bleeding,clinical research

Publications:
2005 -- Pubmed # 16306775 -- Provenzale D, Onken JE. TPMT genotype screening for patients about to begin azathioprine treatment--a look at costs and potential benefits. Inflamm Bowel Dis. 2005 Dec;11(12):1119-20.

2004 -- Pubmed # 14985485 -- Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004 Feb 26;350(9):876-85.

2003 -- Pubmed # 12492734 -- Bloomfeld RS, Onken JE. Mercaptopurine metabolite results in clinical gastroenterology practice. Aliment Pharmacol Ther. 2003 Jan;17(1):69-73.

2002 -- Pubmed # 12425565 -- Onken JE, Friedman JY, Subramanian S, Weinfurt KP, Reed SD, Malenbaum JH, Schmidt T, Schulman KA. Treatment patterns and costs associated with sessile colorectal polyps. Am J Gastroenterol. 2002 Nov;97(11):2896-901.

1998 -- Pubmed # 9750061 -- Eloubeidi MA, Onken JE. Manifestations of Crohn's disease. Dig Dis. 1998 Jul-Aug;16(4):262.

1998 -- Pubmed # 9647011 -- Provenzale D, Wong JB, Onken JE, Lipscomb J. Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis. Am J Gastroenterol. 1998 Jun;93(6):872-80.